Skye Bioscience (SKYE) Institutional Ownership $1.87 -0.25 (-11.79%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.88 +0.00 (+0.27%) As of 03/28/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Skye Bioscience (NASDAQ:SKYE)CurrentInstitutional OwnershipPercentage21.09%Number ofInstitutional Buyers(last 12 months)28TotalInstitutional Inflows(last 12 months)$80.10MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$3.97M Get SKYE Insider Trade Alerts Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SKYE Institutional Buying and Selling by Quarter Remove Ads Skye Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC13,546$38K0.0%N/A0.045% 2/17/2025 Two Sigma Advisers LP11,200$32K0.0%N/A0.037% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.326,241$923K0.0%-5.3%1.075% 2/17/2025 Ensign Peak Advisors Inc767,287$2.17M0.0%-14.7%2.529% 2/17/2025 Deutsche Bank AG40,835$116K0.0%+365.0%0.135% 2/17/2025 Bridgeway Capital Management LLC72,000$204K0.0%+26.3%0.237% 2/17/2025 Braidwell LP825,732$2.34M0.1%N/A2.722% 2/17/2025 Baker BROS. Advisors LP1,450,638$4.11M0.0%+1.1%4.781% 2/17/2025 Bank of America Corp DE39,257$111K0.0%+37.4%0.129% 2/17/2025 BNP Paribas Financial Markets31,637$90K0.0%-33.3%0.104% Get the Latest News and Ratings for SKYE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Alyeska Investment Group L.P.456,163$1.29M0.0%-17.7%1.504% 2/14/2025 Jane Street Group LLC36,057$102K0.0%+195.5%0.119% 2/14/2025 Schonfeld Strategic Advisors LLC1,422,741$4.03M0.0%+48.3%4.689% 2/14/2025 AdvisorShares Investments LLC88,391$250K0.0%-23.1%0.291% 2/14/2025 Northern Trust Corp135,712$384K0.0%-3.7%0.447% 2/14/2025 Altium Capital Management LLC1,139,000$3.22M0.9%-13.4%3.754% 2/13/2025 Barclays PLC69,620$198K0.0%+20.3%0.229% 2/13/2025 Wells Fargo & Company MN11,199$32K0.0%+49.0%0.037% 2/12/2025 Geode Capital Management LLC405,694$1.15M0.0%+5.2%1.337% 2/11/2025 Virtu Financial LLC10,142$29K0.0%N/A0.033% 2/11/2025 Platinum Investment Management Ltd.434,046$1.23M0.1%-10.5%1.431% 2/6/2025 Charles Schwab Investment Management Inc.62,363$176K0.0%+20.7%0.206% 1/1/2025 JPMorgan Chase & Co.11,362$44K0.0%-24.1%0.037% 11/19/2024 Barclays PLC57,889$226K0.0%+36.7%0.191% 11/16/2024 Geode Capital Management LLC385,793$1.51M0.0%+4.2%1.272% 11/15/2024 Barclays PLC57,889$226K0.0%+36.7%0.191% 11/15/2024 Jane Street Group LLC12,200$48K0.0%N/A0.040% 11/15/2024 Sphera Funds Management LTD.1,563,522$6.11M1.0%+20.4%5.153% 11/15/2024 State Street Corp354,205$1.39M0.0%+7.0%1.167% 11/15/2024 Point72 Asset Management L.P.416,424$1.63M0.0%-25.6%1.373% 11/15/2024 Baker BROS. Advisors LP1,434,634$5.61M0.1%+186.9%4.729% 11/13/2024 BNP Paribas Financial Markets47,417$185K0.0%+71.1%0.156% 9/16/2024 Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 9/16/2024 Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 9/16/2024 Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% 8/19/2024 Point72 Asset Management L.P.560,000$4.49M0.0%N/A1.995% 8/16/2024 Perceptive Advisors LLC500,000$4.01M0.1%N/A1.781% 8/16/2024 Driehaus Capital Management LLC650,758$5.21M0.0%N/A2.319% 8/15/2024CVI Holdings LLC679,739$5.45M4.9%N/A2.422% 8/15/2024 Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% DOGE Social Security bombshell? (Ad)Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.>>Here are the NINE stocks everyone will wish they own once Elon moves.<<8/14/2024 Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 8/14/2024 Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 8/14/2024 Logos Global Management LP1,301,518$10.43M0.8%N/A4.637% 8/8/2024 AdvisorShares Investments LLC26,000$210K0.0%N/A0.093% 8/1/2024 Rhumbline Advisers19,754$158K0.0%N/A0.070% 7/26/2024 Bank of New York Mellon Corp58,778$471K0.0%N/A0.209% (Data available from 1/1/2016 forward)Remove Ads SKYE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SKYE shares? During the previous two years, 35 institutional investors and hedge funds held shares of Skye Bioscience. The most heavily invested institutionals were Logos Global Management LP ($10.43M), Sphera Funds Management LTD. ($6.11M), CVI Holdings LLC ($5.45M), Driehaus Capital Management LLC ($5.21M), Baker BROS. Advisors LP ($4.11M), Schonfeld Strategic Advisors LLC ($4.03M), and Perceptive Advisors LLC ($4.01M).Learn more on SKYE's institutional investors. What percentage of Skye Bioscience stock is owned by institutional investors? 21.09% of Skye Bioscience stock is owned by institutional investors. Learn more on SKYE's institutional investor holdings. Which institutional investors have been buying Skye Bioscience stock? Of the 28 institutional investors that purchased Skye Bioscience stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Logos Global Management LP ($1.30M), Baker BROS. Advisors LP ($950.64K), Braidwell LP ($825.73K), CVI Holdings LLC ($679.74K), Driehaus Capital Management LLC ($650.76K), Point72 Asset Management L.P. ($560K), and Perceptive Advisors LLC ($500K). How much institutional buying is happening at Skye Bioscience? Institutional investors have bought a total of 6,641,170 shares in the last 24 months. This purchase volume represents approximately $80.10M in transactions. Which Skye Bioscience major shareholders have been selling company stock? Of the 10 institutional investors that sold Skye Bioscience stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Altium Capital Management LLC ($176.15K), Point72 Asset Management L.P. ($143.58K), Ensign Peak Advisors Inc ($132.71K), Alyeska Investment Group L.P. ($98.01K), Platinum Investment Management Ltd. ($51.15K), AdvisorShares Investments LLC ($26.61K), and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($18.21K). How much institutional selling is happening at Skye Bioscience? Institutional investors have sold a total of 670,983 shares in the last 24 months. This volume of shares sold represents approximately $3.97M in transactions. Related Companies SEPN Major Shareholders CADL Major Shareholders DSGN Major Shareholders AVIR Major Shareholders CRVS Major Shareholders MBX Major Shareholders IMMP Major Shareholders PRME Major Shareholders SLRN Major Shareholders ITOS Major Shareholders This page (NASDAQ:SKYE) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
